Parexel
Sustainability Report and Carbon Intensity Rankings
Is Parexel doing their part?
Their DitchCarbon score is 71
Parexel has a DitchCarbon Score of 71, indicating a relatively high level of sustainability in its operations. This score reflects the company’s commitment to reducing its carbon intensity. A score of 71 suggests that Parexel is actively working towards lower emissions in comparison to its industry peers.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
Parexel, a company in the research and development sector, has a very low carbon intensity ranking. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Medium
High
Very high
Parexel, located in the United States, benefits from a low carbon intensity rating in the region. This suggests that the company’s sustainability efforts are supported by the country’s overall lower environmental impact.
Unlock 30+ emissions data points on Parexel
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on Parexel
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
19.64%
...this company is doing 19.64% better in emissions than the industry average.
Founded in 1982 and headquartered in Waltham, near Boston, Massachusetts, PAREXEL operates within the research and development sector of the biopharmaceutical industry. As a global company, it has a presence in 86 locations across 51 countries, employing over 19,300 people. PAREXEL offers integrated solutions that span from product strategy and clinical development to market access and life-cycle management, aiming to expedite the delivery of new treatments to patients.
emission intelligence's platform recommendations for Parexel
Parexel should set clear, science-based targets for reducing their Scope 3 emissions, maintain transparency in reporting their progress, and promote environmental sustainability throughout their supply chain, which could potentially lower their emissions by 35%.
Good news, Parexel has made solid SBTi commitments
Parexel has pledged to set science-based emissions reduction targets through the Science Based Targets initiative (SBTi). This commitment means the company aims to align its carbon reduction strategies with the level of decarbonization required to limit global warming, as per the latest climate science.
Participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.